Dr. Kharrazian was recently appointed a research fellow at Harvard Medical School and the Department of Neurology at Massachusetts General Hospital.
His research will focus on neuroimmunology, neurotoxicology, and autoimmunity.
He is also studying how infections and toxins can impact the brain using advanced neuroimaging spectroscopy, a type of brain scan. This research is being done at the Transcend laboratory with esteemed neuroscientist and neurologist Martha Herbert, MD, PhD.
Dr. Kharrazian’s research career began in 2007 after earning a Doctorate of Health Science degree, with a focus on medical research, from Nova Southeastern University.
He then became an associate clinical professor at Loma Linda University School of Medicine.
In 2014, Dr. Kharrazian completed a one-year post-doctorate program in the Global Clinical Research Training Program at Harvard Medical School. He graduated from the program with distinction and was accepted into the Harvard Medical School and Harvard University Alumni Association.
Dr. Kharrazian then returned to Harvard Medical School in the summer of 2016 as one of 12 researchers accepted into a rigorous, two-year post-doctorate residential program — the Master of Medical Sciences in Clinical Investigation. He is currently in this program.
Some of the best statisticians, epidemiologists, and researchers in the world are Dr. Kharrazian’s mentors in this program. The goal of the program is to train and develop future leaders of medical research.
Harvard Medical School leading medical research institution in the world
Harvard Medical School has always been a leader in medicine. Consider some of the ares of research happening there:
- Intestinal permeability
- Celiac disease
- The role of the gut microbiome in brain function and nutrition
Harvard Medical School has been ranked number one in medical research consecutively for the past 85 years by every major university ranking authority in the world.
Dr. Kharrazian’s research at Harvard will examine the influence of various dietary and environmental factors on the growing epidemic of brain and autoimmune diseases.